NUTANIX INC - A (NTNX) Fundamental Analysis & Valuation

NASDAQ:NTNXUS67059N1081

Current stock price

40.56 USD
+1.41 (+3.6%)
At close:
40.56 USD
0 (0%)
After Hours:

This NTNX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. NTNX Profitability Analysis

1.1 Basic Checks

  • In the past year NTNX was profitable.
  • In the past year NTNX had a positive cash flow from operations.
  • In the past 5 years NTNX reported 4 times negative net income.
  • NTNX had a positive operating cash flow in 4 of the past 5 years.
NTNX Yearly Net Income VS EBIT VS OCF VS FCFNTNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 8.15%, NTNX belongs to the top of the industry, outperforming 81.99% of the companies in the same industry.
  • NTNX's Return On Invested Capital of 11.11% is amongst the best of the industry. NTNX outperforms 87.13% of its industry peers.
Industry RankSector Rank
ROA 8.15%
ROE N/A
ROIC 11.11%
ROA(3y)-3.39%
ROA(5y)-17.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NTNX Yearly ROA, ROE, ROICNTNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200

1.3 Margins

  • NTNX's Profit Margin of 9.95% is fine compared to the rest of the industry. NTNX outperforms 73.90% of its industry peers.
  • NTNX has a Operating Margin of 8.30%. This is in the better half of the industry: NTNX outperforms 73.16% of its industry peers.
  • Looking at the Gross Margin, with a value of 87.13%, NTNX belongs to the top of the industry, outperforming 93.38% of the companies in the same industry.
  • NTNX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.3%
PM (TTM) 9.95%
GM 87.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.89%
GM growth 5Y2.14%
NTNX Yearly Profit, Operating, Gross MarginsNTNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

3

2. NTNX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NTNX is still creating some value.
  • NTNX has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, NTNX has more shares outstanding
  • The debt/assets ratio for NTNX is higher compared to a year ago.
NTNX Yearly Shares OutstandingNTNX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
NTNX Yearly Total Debt VS Total AssetsNTNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 0.79, we must say that NTNX is in the distress zone and has some risk of bankruptcy.
  • NTNX has a Altman-Z score of 0.79. This is in the lower half of the industry: NTNX underperforms 63.97% of its industry peers.
  • NTNX has a debt to FCF ratio of 1.74. This is a very positive value and a sign of high solvency as it would only need 1.74 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 1.74, NTNX is doing good in the industry, outperforming 68.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.74
Altman-Z 0.79
ROIC/WACC1.05
WACC10.57%
NTNX Yearly LT Debt VS Equity VS FCFNTNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

2.3 Liquidity

  • NTNX has a Current Ratio of 1.65. This is a normal value and indicates that NTNX is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of NTNX (1.65) is comparable to the rest of the industry.
  • NTNX has a Quick Ratio of 1.65. This is a normal value and indicates that NTNX is financially healthy and should not expect problems in meeting its short term obligations.
  • NTNX has a Quick ratio (1.65) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.65
NTNX Yearly Current Assets VS Current LiabilitesNTNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

6

3. NTNX Growth Analysis

3.1 Past

  • NTNX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.03%, which is quite good.
  • NTNX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.85%.
  • Measured over the past years, NTNX shows a quite strong growth in Revenue. The Revenue has been growing by 14.18% on average per year.
EPS 1Y (TTM)15.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)15.85%
Revenue growth 3Y17.09%
Revenue growth 5Y14.18%
Sales Q2Q%10.4%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.32% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 19.77% on average over the next years. This is quite good.
EPS Next Y6.23%
EPS Next 2Y12.35%
EPS Next 3Y13.32%
EPS Next 5YN/A
Revenue Next Year11.72%
Revenue Next 2Y12.37%
Revenue Next 3Y12.3%
Revenue Next 5Y19.77%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NTNX Yearly Revenue VS EstimatesNTNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B
NTNX Yearly EPS VS EstimatesNTNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

4

4. NTNX Valuation Analysis

4.1 Price/Earnings Ratio

  • NTNX is valuated rather expensively with a Price/Earnings ratio of 23.05.
  • 63.97% of the companies in the same industry are more expensive than NTNX, based on the Price/Earnings ratio.
  • NTNX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.42.
  • The Price/Forward Earnings ratio is 18.15, which indicates a rather expensive current valuation of NTNX.
  • NTNX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NTNX is cheaper than 68.01% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of NTNX to the average of the S&P500 Index (22.24), we can say NTNX is valued inline with the index average.
Industry RankSector Rank
PE 23.05
Fwd PE 18.15
NTNX Price Earnings VS Forward Price EarningsNTNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 65.81% of the companies in the same industry are more expensive than NTNX, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, NTNX is valued cheaply inside the industry as 82.72% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.84
EV/EBITDA 29.05
NTNX Per share dataNTNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NTNX does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as NTNX's earnings are expected to grow with 13.32% in the coming years.
PEG (NY)3.7
PEG (5Y)N/A
EPS Next 2Y12.35%
EPS Next 3Y13.32%

0

5. NTNX Dividend Analysis

5.1 Amount

  • No dividends for NTNX!.
Industry RankSector Rank
Dividend Yield 0%

NTNX Fundamentals: All Metrics, Ratios and Statistics

NUTANIX INC - A

NASDAQ:NTNX (4/24/2026, 8:00:02 PM)

After market: 40.56 0 (0%)

40.56

+1.41 (+3.6%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-25
Earnings (Next)05-26
Inst Owners91.32%
Inst Owner Change-0.04%
Ins Owners0.33%
Ins Owner Change1.65%
Market Cap10.76B
Revenue(TTM)2.69B
Net Income(TTM)267.13M
Analysts78.4
Price Target60.09 (48.15%)
Short Float %4.86%
Short Ratio2.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.42%
Min EPS beat(2)-1.7%
Max EPS beat(2)22.55%
EPS beat(4)3
Avg EPS beat(4)10.22%
Min EPS beat(4)-1.7%
Max EPS beat(4)22.55%
EPS beat(8)7
Avg EPS beat(8)23.6%
EPS beat(12)11
Avg EPS beat(12)32.74%
EPS beat(16)15
Avg EPS beat(16)47.29%
Revenue beat(2)0
Avg Revenue beat(2)-1.52%
Min Revenue beat(2)-2.85%
Max Revenue beat(2)-0.18%
Revenue beat(4)1
Avg Revenue beat(4)-0.78%
Min Revenue beat(4)-2.85%
Max Revenue beat(4)0.07%
Revenue beat(8)4
Avg Revenue beat(8)-0.26%
Revenue beat(12)7
Avg Revenue beat(12)0.16%
Revenue beat(16)10
Avg Revenue beat(16)0.84%
PT rev (1m)-8.39%
PT rev (3m)-16.24%
EPS NQ rev (1m)-2.01%
EPS NQ rev (3m)-17.09%
EPS NY rev (1m)1.44%
EPS NY rev (3m)2.71%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-1.87%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.69%
Valuation
Industry RankSector Rank
PE 23.05
Fwd PE 18.15
P/S 4.01
P/FCF 13.84
P/OCF 12.93
P/B N/A
P/tB N/A
EV/EBITDA 29.05
EPS(TTM)1.76
EY4.34%
EPS(NY)2.23
Fwd EY5.51%
FCF(TTM)2.93
FCFY7.22%
OCF(TTM)3.14
OCFY7.74%
SpS10.13
BVpS-3.13
TBVpS-3.84
PEG (NY)3.7
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 8.15%
ROE N/A
ROCE 12.48%
ROIC 11.11%
ROICexc N/A
ROICexgc N/A
OM 8.3%
PM (TTM) 9.95%
GM 87.13%
FCFM 28.94%
ROA(3y)-3.39%
ROA(5y)-17.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.89%
GM growth 5Y2.14%
F-Score8
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.74
Debt/EBITDA 4.56
Cap/Depr 75.78%
Cap/Sales 2.05%
Interest Coverage 250
Cash Conversion 281.44%
Profit Quality 290.91%
Current Ratio 1.65
Quick Ratio 1.65
Altman-Z 0.79
F-Score8
WACC10.57%
ROIC/WACC1.05
Cap/Depr(3y)95.49%
Cap/Depr(5y)80.88%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y6.23%
EPS Next 2Y12.35%
EPS Next 3Y13.32%
EPS Next 5YN/A
Revenue 1Y (TTM)15.85%
Revenue growth 3Y17.09%
Revenue growth 5Y14.18%
Sales Q2Q%10.4%
Revenue Next Year11.72%
Revenue Next 2Y12.37%
Revenue Next 3Y12.3%
Revenue Next 5Y19.77%
EBIT growth 1Y223.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.58%
EBIT Next 3Y24.98%
EBIT Next 5YN/A
FCF growth 1Y97.6%
FCF growth 3Y243.65%
FCF growth 5YN/A
OCF growth 1Y79.09%
OCF growth 3Y129.97%
OCF growth 5YN/A

NUTANIX INC - A / NTNX Fundamental Analysis FAQ

What is the fundamental rating for NTNX stock?

ChartMill assigns a fundamental rating of 4 / 10 to NTNX.


What is the valuation status of NUTANIX INC - A (NTNX) stock?

ChartMill assigns a valuation rating of 4 / 10 to NUTANIX INC - A (NTNX). This can be considered as Fairly Valued.


How profitable is NUTANIX INC - A (NTNX) stock?

NUTANIX INC - A (NTNX) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for NTNX stock?

The Price/Earnings (PE) ratio for NUTANIX INC - A (NTNX) is 23.05 and the Price/Book (PB) ratio is -12.94.


Can you provide the financial health for NTNX stock?

The financial health rating of NUTANIX INC - A (NTNX) is 3 / 10.